Tecelra is part of the T Cell Receptor Therapeutic class and treats Soft Tissue Sarcoma. T cell receptor therapeutics are used to treat melanoma. They work by activating T cells to recognize and destroy tumor cells. Tecelra is only available as a brand name drug.